KL

Kelli Luginbuhl

Chief Executive Officer

Isolere Bio

Durham, North Carolina


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Isolere Bio
Industry
research
Employees
23.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
7250000.0
Latest Funding
Seed

Technologies

CSC Corporate Domains Outlook Microsoft Office 365 Gmail Google Apps Amazon AWS Google Tag Manager Workday Recruit Mobile Friendly Linkedin Marketing Solutions Squarespace ECommerce YouTube Remote Viewpoint

Keywords

biotechnology research bioprocessing affinity ligands phase separation purification reagents isotag aav purification lentiviral production non-chromatographic process biologic manufacturing high yield high purity tangential flow filtration alps process viral vector purification mrna vaccine dsrna removal recombinant proteins clinical scale commercial production biotherapeutic manufacturing process optimization cell culture gmp production biomanufacturing solutions biotechnology viral vector stability scale-up purification technologies biopharmaceuticals affinity capture target specificity environmental stimuli complex biologics separation technologies genomic therapeutics reagent development bioengineering pharmaceutical optimization nucleic acid purification bioprocess development integrative filtration viral particle purification protein engineering cellular contaminants laboratory services technical resources research development deadly disease treatments immunotherapies biological scalability

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans